RMC No. 27-2026: Updated FDA List of VAT-Exempt Drugs for Cancer, Diabetes, Hypertension, and Other Illnesses

RMC No. 27-2026 updates the FDA-endorsed VAT-exempt drug list for cancer, diabetes, hypertension, kidney disease, mental illness, and more. Businesses selling covered medicines must immediately check whether their pharmacy, hospital, distribution, accounting, and point-of-sale systems reflect the updated VAT-exempt drug list endorsed by the Food and Drug Administration. RMC No. 27-2026 publishes the updated full […]

RMC No. 4-2019: VAT Exemption for FDA-Listed Diabetes, High-Cholesterol, and Hypertension Drugs

RMC No. 4-2019 publishes the FDA list of VAT-exempt diabetes, high-cholesterol, and hypertension drugs for pharmacy and healthcare VAT compliance. Pharmacies, hospitals, drug distributors, and VAT-registered sellers of medicine must treat the FDA-identified drugs for diabetes, high cholesterol, and hypertension as VAT-exempt once covered by the published FDA list. RMC No. 4-2019 matters because the […]